Letrohope 2.5 Tablet
1,34$
0,94$
Letrohope 2.5 Tablet is an effective aromatase inhibitor primarily prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By inhibiting the aromatase enzyme, Letrohope significantly reduces estrogen levels in the body, thereby slowing or stopping the growth of certain types of breast tumors that rely on this hormone. This medication is also valuable in lowering the risk of cancer recurrence after initial treatment, providing patients with an additional layer of protection against this serious disease. It’s essential to discuss your complete medical history with your healthcare provider before starting Letrohope, as it may not be suitable for individuals with a history of certain conditions or those who are pregnant or breastfeeding. Common side effects can include hot flashes, fatigue, and joint pain, so monitoring is crucial during treatment. With its targeted approach, Letrohope 2.5 Tablet plays a vital role in modern breast cancer management, offering hope and improved outcomes for many women. Always follow your doctor's instructions regarding dosage and report any unusual symptoms promptly for optimal safety and efficacy.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Letrohope •5 tablet is primarily used in the treatment of certain hormone-sensitive cancers, particularly breast cancer. It works by lowering estrogen levels in the body, which can help slow or stop the growth of cancer cells that require estrogen to proliferate. Patients often take Letrohope •5 as part of a comprehensive treatment plan that may include surgery and radiation. This medication is typically prescribed for postmenopausal women, making it an essential part of their cancer management.
• In addition to treating breast cancer, Letrohope •5 tablet may be utilized for conditions related to hormonal imbalances. It helps regulate estrogen levels, which can be beneficial for women experiencing issues linked to excess estrogen. By managing these levels, Letrohope •5 can contribute to improved overall health and well-being in patients facing hormonal challenges. This medication can be an important option for those looking to balance their hormonal profile.
• Letrohope •5 tablet is also indicated for patients undergoing certain fertility treatments. It can help stimulate ovulation by reducing estrogen levels, thereby allowing for better follicular development. This use of Letrohope •5 is particularly relevant for women with specific reproductive challenges, as it supports their chances of conception. By integrating Letrohope •5 into their treatment, patients may experience enhanced fertility outcomes.
• For women diagnosed with conditions such as endometriosis, Letrohope •5 tablet can be a valuable component of their therapeutic regimen. It aids in the management of symptoms by lowering estrogen levels, which can alleviate pain and discomfort associated with this condition. Letrohope •5 is often prescribed when other treatments have not yielded satisfactory results. This medication plays a significant role in providing relief and improving quality of life for those affected by endometriosis.
Benefits
Letrohope 2.5 Tablet belongs to a class of drugs called aromatase inhibitors. It inhibits the enzyme aromatase, which plays a crucial role in the production of estrogen. By blocking aromatase, Letrohope 2.5 effectively lowers estrogen levels, which is beneficial in hormone-dependent breast cancers. Letrohope 2.5 Tablet is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It helps to slow down or stop the growth of breast cancer cells by reducing the levels of estrogen in the body. Letrohope 2.5 Tablet can improve disease-free survival rates in postmenopausal women with hormone receptor-positive breast cancer when compared to other hormonal therapies. Letrohope 2.5 Tablet is commonly used as adjuvant therapy after surgery or other primary treatments for breast cancer. It helps to reduce the risk of cancer recurrence and improves the chances of long-term remission. Letrohope 2.5 has also been explored for off-label uses, such as fertility treatment in women with polycystic ovary syndrome (PCOS) who are trying to conceive. In such cases, Letrohope 2.5 Tablet helps induce ovulation by suppressing estrogen production. It's important to note that while Letrohope 2.5 Tablet has several benefits, it should only be used under the guidance of a healthcare professional. The appropriate use of Letrohope 2.5 Tablet depends on individual factors and should be discussed with a qualified medical practitioner.
Side Effects
Like all medication, Letrohope 2.5 Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• High Blood Pressure
• Hot Flashes
• Vomiting
• Diarrhoea
• Hair Thinness
• Weight Gain
• Vaginal Dryness
• Appetite Loss
• Skin Dryness
• High Levels of Cholesterol
• Pain in Muscles and Bones
• Swelling
Common Side Effects
• Coughing of Blood
• Fainting
• Liver Inflammation
• Breathlessness
• Vision Changes
• Allergic Reactions
• Fainting
How To Use
Letrohope 2.5 Tablet can be taken with or without food. Try to take your Letrohope 2.5 at the same time each day. You can choose a time that suits your everyday routine. This will make it easier to remember to take your medicine. Swallow the tablet whole with a drink of water. Do not crush or chew it. If you forget a dose take it as soon as you remember, unless your next dose is due in 2 or 3 hours. In this case, skip the missed dose and take your next one at the usual time. Do not take a double dose to make up for a forgotten dose.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Letrohope 2.5 Tablet. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Letrohope 2.5. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Letrohope 2.5 Tablet is safe for use in kidney disease patients. No dosage adjustment is required for kidney patients with creatinine clearance greater than 10 mL/min. Please consult your doctor if you have kidney impairment or any concerns.
• Breastfeeding: It is not recommended to breastfeed while taking Letrohope 2.5. Letrohope 2.5 Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Letrohope 2.5, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Letrohope 2.5 Tablet is safe for mild to moderate liver disease patients. No dosage adjustment is required for mild to moderate liver disease patients. In severe liver disease, patients are used with caution. Dose adjustment of Letrohope 2.5 may be needed. Please consult your doctor.
• Pregnancy: Use of Letrohope 2.5 Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Letrohope 2.5 during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Letrohope 2.5 Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Letrohope 2.5.